학술논문
Dose-Adjusted EPOCH Plus Inotuzumab Ozogamicin in Adults with Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial
Document Type
Article
Author
Source
In: JAMA Oncology . (JAMA Oncology, 2024)
Subject
Language
English
ISSN
23742445
23742437
23742437